3-Glycidoxypropyltrimethoxysilane

We are 3-Glycidoxypropyltrimethoxysilane CAS:2530-83-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Chemical Name:3-Glycidoxypropyltrimethoxysilane
CAS.NO:2530-83-8
Synonyms:gamma-Glycidoxypropyltrimethoxysilane; 3-(2,3-Epoxypropoxypropyl)trimethoxysilane;
Molecular Formula:C9H20O5Si
Molecular Weight:236.33800
 
Physical and Chemical Properties:
Density:1.070;
Melting point:-50oC;
Boiling point:120oC;
Flash point:110oC;
Index of Refraction:1.429;
 
Specification:
Appearance:Colorless transparent liquid
Purity(GC):≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It may improve dry and wet strength in cured composites reinforced with glass fiber rovings.
It may enhance wet electrical properties of epoxy-based encapsulate and packaging materials.
It may eliminate the need for a separate primer in polysulfide and urethane sealants.
It may improve adhesion in waterborne acrylic sealants and in urethane and epoxy coatings.

3-Glycidoxypropyltrimethoxysilane


Related News: Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.1-bromohexadecano CAS:112-82-3 From the perspective of the overall life cycle of generic drugs from R & D to sales, with the expiration of patents, the business model for the production and marketing of generic pharmaceutical raw materials has changed, demand has increased, business potential has been realized quickly, and gross profit margins have shown a downward trend.51828-93-4 Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.1-Bromo-3,3-Dimethyl-Butane CAS:1647-23-0 Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.Since inception in 2004, ICIG has acquired 15 businesses, all of which have origins in major global chemical or pharmaceutical corporations and are independently managed.

Related Products
Product Name
5-(2-hydroxyethyl)-4-methylthiazole View Details
Indolo[2,3-a]carbazole View Details
N-(4-Cyanophenyl)guanidine View Details
DL-Phenylalanine manufacturer [4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]methyl-triphenylphosphanium,bromide manufacturer 4-amino-2,3-dihydroisoindol-1-one manufacturer 2-Bromo-5-fluorobenzoic acid manufacturer (5-Bromo-2-methylphenyl)[5-(4-fluorophenyl)-2-thienyl]methanone manufacturer